Anterix Inc.
ATEX
$36.55
-$0.65-1.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.51% | 5.67% | 15.97% | 43.90% | 66.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.51% | 5.67% | 15.97% | 43.90% | 66.77% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.51% | 5.67% | 15.97% | 43.90% | 66.77% |
| SG&A Expenses | -13.37% | -16.13% | -11.27% | -2.66% | -3.45% |
| Depreciation & Amortization | -34.09% | -33.94% | -36.55% | -35.07% | -31.37% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.15% | -18.61% | -12.54% | -2.81% | -0.10% |
| Operating Income | 18.08% | 21.15% | 15.25% | 6.54% | 4.53% |
| Income Before Tax | 394.80% | 391.92% | 242.58% | -26.15% | -258.76% |
| Income Tax Expenses | 256.89% | 114.32% | -151.61% | 17.30% | -54.29% |
| Earnings from Continuing Operations | 371.16% | 355.89% | 230.17% | -24.58% | -289.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 371.16% | 355.89% | 230.17% | -24.58% | -289.52% |
| EBIT | 18.08% | 21.15% | 15.25% | 6.54% | 4.53% |
| EBITDA | 17.87% | 20.98% | 14.93% | 6.08% | 4.04% |
| EPS Basic | 368.85% | 354.03% | 228.92% | -24.86% | -293.04% |
| Normalized Basic EPS | 17.49% | 20.25% | 14.17% | 5.05% | 4.21% |
| EPS Diluted | 367.00% | 352.92% | 227.91% | -26.91% | -295.23% |
| Normalized Diluted EPS | 17.60% | 20.47% | 14.14% | 4.87% | 3.89% |
| Average Basic Shares Outstanding | 0.54% | 0.32% | -0.27% | -1.06% | -1.67% |
| Average Diluted Shares Outstanding | 0.62% | 0.58% | -0.28% | -1.19% | -1.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |